Vol 42 - N° 3 - mars 2025
P. 117-186© SPLF
Rev. Mal. Respir. March 2025; 42(3): i. Publication en ligne : 24 March 2025
PDF HTML accès libreOn your marks, get set, go for the 20th edition of J2R 2024 in Paris!
I. Annesi-Maesano, P. Bonniaud, G. Bouchaud, L. Boyer, P. Gosset, D. Gras, C. Guignabert, M.Z. Ladjemi, S. Matecki, C. Morelot, C. Pilette, C. Planes, L. Plantier, M. Polette, M. Si-Tahar, C. Taillé, L.-E. Zaragosi, I. Vachier, B. Mari, C. Guibert, membres du groupe RESPIRenT
Rev. Mal. Respir. March 2025; 42(3): 117-120. Publication en ligne : 24 March 2025
Impact of Rac1 activation on eosinophil degranulation in severe asthma
H. Bergereau, D. Hassoun, Q. Marquant, M. Rousselle, A. Magnan, G. Loirand, V. Sauzeau
Rev. Mal. Respir. March 2025; 42(3): 121-4. Publication en ligne : 24 March 2025
Targeting the TGF-β pathway in pulmonary fibrosis: Is it still a relevant strategy?
L. Biziorek, M. Dériot, P. Bonniaud, F. Goirand, O. Burgy
Rev. Mal. Respir. March 2025; 42(3): 125-9. Publication en ligne : 24 March 2025
Impact of preconditioning to anxiety followed by exposure to air pollution on the pathophysiology of cystic fibrosis
C.-H. Yegen, C. Boucheniata, M. Bourenane, C. Macias, C. Buissot, M. Georgopoulos, M. Cazaunau, A. Bergé, A. Der Vartanian, R. Souktani, R. Epaud, S.N. Pandis, P. Coll, S. Lanone
Rev. Mal. Respir. March 2025; 42(3): 130-3. Publication en ligne : 24 March 2025
Senescence of the pulmonary endothelial cells: VEGF, a new target in pulmonary pathologies and aging
J. Jacquet, E. Marcos, L. Lipskaia, V. Gros, E. Born, A. Houssaini, S. Adnot, L. Boyer
Rev. Mal. Respir. March 2025; 42(3): 134-7. Publication en ligne : 24 March 2025
Dyspnea and cortical brain activation measured by functional near-infrared spectroscopy during a mechanical ventilation weaning trial
G. Kemoun, D. Jimenez, M.C. Nierat, N. Wattiez, D. Bachasson, J. Mayaux, M. Lecronier, T. Similowski, A. Demoule, M. Dres, M. Decavèle
Rev. Mal. Respir. March 2025; 42(3): 138-142. Publication en ligne : 24 March 2025
Long non-coding RNAs, new therapeutic targets for the treatment of non-small cell lung cancers?
R. Lopes Goncalves, M. Gauthier-Isola, G. Vassaux, B. Mari, R. Rezzonico
Rev. Mal. Respir. March 2025; 42(3): 143-7. Publication en ligne : 24 March 2025
Post-infectious bronchiolitis obliterans in children: A rare and potentially devastating disease
J. Mazenq, J.-C. Dubus, P. Chanez, D. Gras
Rev. Mal. Respir. March 2025; 42(3): 148-152. Publication en ligne : 24 March 2025
In vitro preclinical models reproducing the respiratory epithelium: Application to the study of SARS-CoV-2 virus infection
L. Morichon, S. Assou, A. Bourdin, D. Muriaux, J. De Vos
Rev. Mal. Respir. March 2025; 42(3): 153-8. Publication en ligne : 24 March 2025
Wildfires and their respiratory impact
D. Charpin, O. Brun
Rev. Mal. Respir. March 2025; 42(3): 159-167. Publication en ligne : 24 March 2025
Update of guidelines for management of Community Acquired pneumonia in adults by French Infectious Disease Society (SPILF) and the French Speaking Society of Respiratory Diseases (SPLF). Endorsed by French intensive care society (SRLF), French microbiology society (SFM), French radiology society (SFR), French emergency society (SFMU)
A. Dinh, F. Barbier, J.-P. Bedos, M. Blot, V. Cattoir, Y.-E. Claessens, X. Duval, P. Fillâtre, M. Gautier, Y. Guegan, S. Jarraud, A. Le Monnier, D. Lebeaux, P. Loubet, C. de Margerie, P. Serayet, Y. Tandjaoui-Lambotte, E. Varon, Y. Welker, D. Basille
Rev. Mal. Respir. March 2025; 42(3): 168-186. Publication en ligne : 24 March 2025